AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-34089303_ITM" title="Facts and information about Approved: lisdexamfetamine for ADHD.(From the FDA)(Brief article)">Approved: lisdexamfetamine for ADHD.(From the FDA)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Brown University Psychopharmacology Update are available.
Frequently asked questions about RSS feeds
Approved: lisdexamfetamine for ADHD.(From the FDA)(Brief article)
On February 23 the FDA announced the approval of a new amphetamine-based drug--lisdexamfetamine dimesylate--to treat attention deficit hyperactivity disorder (ADHD) in children 6 to 12 years old. Maker Shire PLC claims that its drug Vyvanse …
Related articles from newspapers, magazines, journals, and more
-
- New approval.(From the FDA)(Brief article)
-
Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update
December 1, 2009
700+ words
-
- New approval: INTUNIV.(From the FDA)(Brief article)
-
Magazine article from: Brown University Psychopharmacology Update
December 1, 2009
700+ words
-
- New approvals.(From the FDA)(dexmethylphenidate)(Brief article)
-
Newspaper article from: The Brown University Geriatric Psychopharmacology Update
April 1, 2007
700+ words
-
- FDA approves Vyvanse label change.(From the FDA)(Brief article)
-
Magazine article from: Brown University Psychopharmacology Update
July 1, 2010
700+ words
-
- Investigational MAS for adult ADHD.(News Notes)(mixed amphetamine...
-
Magazine article from: Brown University Psychopharmacology Update
February 1, 2007
700+ words
